Quantcast

Latest NeoGenomics Inc. Stories

2011-04-15 14:17:00

FORT MYERS, Fla., April 15, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its first quarter 2011 financial results on Thursday, April 21, 2011. The Company has scheduled a web-cast and conference call to discuss their Q1 2011 results on April 21, 2011, at 11:00 AM eastern time. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior to the call. A replay of the...

2011-02-10 06:00:00

FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010. Fourth Quarter 2010 Highlights: Revenue growth of 12% Adjusted EBITDA positive Average revenue per test stabilized Diluted loss per share of $(0.01) Revenue for the fourth quarter 2010 was approximately $8.8 million, a 12% increase...

2011-02-10 05:30:00

FT. MYERS, Fla., Feb. 10, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services announced today that Kevin C. Johnson and Raymond R. Hipp have joined its Board of Directors. Mr. Johnson's appointment was effective October 28, 2010 and filled the vacancy created by the resignation of Mr. George O'Leary. Mr. Hipp's appointment was effective as of February 3, 2011 and filled the vacancy created by the resignation of...

2011-02-04 14:49:00

FT. MYERS, Fla., Feb. 4, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it plans to release its fourth quarter and full year 2010 financial results on Thursday, February 10, 2011. The Company has scheduled a web-cast and conference call to discuss their Q4 and Full Year 2010 results on February 10, 2011, at 11:00 AM eastern time. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior...

2011-01-12 06:00:00

FT. MYERS, Fla., Jan. 12, 2011 /PRNewswire/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it has completed a $3.0 million equity financing transaction. Five members of the Company's Board of Directors and senior management team and two existing institutional investors of the Company participated in the transaction. The transaction was priced at $1.50 per share and resulted in 2.0 million shares of new common stock being issued by the Company. No warrants were...

2011-01-11 06:00:00

FT. MYERS, Fla., Jan. 11, 2011 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) announced today that it has been notified that the Qui Tam complaint filed against it and several other healthcare companies in 2009 has been voluntarily dismissed with prejudice by the relator in the case. As a result, no further action will be taken against NeoGenomics in this matter. Douglas VanOort, the Company's Chairman and CEO, stated, "We are pleased, but not surprised that this case...

2010-11-15 06:00:00

FT. MYERS, Fla., Nov. 15, 2010 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it will present at the Lazard Capital Markets 7th Annual Healthcare Conference being held November 16-17, 2010, at the St. Regis, New York Hotel in New York City. The conference will showcase public and private life sciences and biotech companies. Senior executives of attending companies will make presentations to portfolio managers and analysts on their business...

2010-11-04 12:34:00

FT. MYERS, Fla., Nov. 4, 2010 /PRNewswire-FirstCall/ --- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported that it had been awarded two research and development grants totaling $374,479 from the US government under HR: 3590 - Patient Protection and Affordable Care Act (the "Act"). Under the Act, $1 billion was earmarked for qualifying therapeutic discovery projects that show the potential to produce new cost saving...

2010-10-28 06:00:00

FT. MYERS, Fla., Oct. 28 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter 2010. Third Quarter 2010 Highlights: Revenue growth of 19 % vs. Q3 2009 Test volume growth of 29% vs. Q3 2009 Average revenue/test increased by 2.5% sequentially vs. Q2 2010 Completed implementation of next generation laboratory information system Revenue for the three months...

2010-10-20 12:52:00

FT. MYERS, Fla., Oct. 20 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) announced today that it plans to release its third quarter 2010 financial results on Thursday, October 28, 2010. The Company has scheduled a web-cast and conference call to discuss their Q3 2010 results on October 28, 2010, at 11:00 AM EDT. Interested investors should dial (877) 407-8033 (domestic) and (201) 689-8033 (international) at least five minutes prior to the call. A replay of the...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related